Ledger.Open graph →
SEC Form D · Amendment · filed January 21, 2014

Actinium Pharmaceuticals, Inc

Offering
$6.6M
Sold
$6.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Dragan J. Cicic · New York, NYExecSergio J. Traversa · New York, NYExec · DirectorRichard I. Steinhart · New York, NYDirectorKaushik J. Dave · New York, NYExec · DirectorDavid J. Nicholson · New York, NYDirectorSandesh J. Seth · New York, NYDirectorFrancoise Chung Kee Mew · Ebere, O4ExecPhilip Walters · Singapore, U0DirectorNadia Cesaratto · Montreal, Quebec, CanadaExec · DirectorVital Proulx · Montreal, Quebec, CanadaExec · DirectorMarc Lavoie · Montreal, Quebec, CanadaDirectorThomas E. Faust, Jr · Suite 4200, Quebec, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗